

See product citations (1)
QUICK LINKS
AGL 2263 is a cell-permeable benzoxazolone-containing bioisostere of tyrphostin AG 538 that acts as a potent, substrate-competitive, but not ATP-competitive, inhibitor of IR (insulin receptor) and IGF-IR (insulin-like growth factor-1 receptor). AGL 2263 is selective towards IR and IGF-IR (IC50 = 0.4 and 0.43 muM, respectively) and inhibits c-Src (Src) and Akt (PKB) at much higher concentrations (IC50 = 2.2 and 55 muM, respectively) in kinase assays. AGL 2263 may act to prevent IGF-1-induced cellular IGF-IR autophosphorylation and down stream signalling. Specifically inhibits IGF-1-induced, but not PDGF-induced, activation of Akt (PKB) in cells. AGL 2263 effectively blocks the formation of colonies in soft agar by breast and prostate cancer cells. Exhibits improved cellular oxidative stability than AG 538.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AGL 2263, 5 mg | sc-221223 | 5 mg | $357.00 |